Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Lung Cancer EGFR 2026

Tetsuya Mitsudomi

光冢哲也

MD, PhD

🏢Kindai University Faculty of Medicine(近畿大学医学部)🌐Japan

Professor and Chair, Division of Thoracic Surgery; Director, Thoracic Oncology Program胸外科主任教授;胸部肿瘤项目主任

65
h-index
2
Key Papers
3
Awards
2
Key Contributions

👥Biography 个人简介

Japan's foremost thoracic surgical oncologist and EGFR research pioneer. Led the IMPACT trial evaluating gefitinib as adjuvant therapy in Japanese EGFR-mutant NSCLC after complete resection, and established foundational EGFR mutation detection methodologies widely adopted in Asia.

Share:

🧪Research Fields 研究领域

EGFR Gefitinib SurgeryEGFR吉非替尼手术
IMPACT TrialIMPACT试验
EGFR Japan日本EGFR
Surgical Oncology NSCLC非小细胞肺癌外科肿瘤学
EGFR Mutation DetectionEGFR突变检测

🎓Key Contributions 主要贡献

IMPACT Trial - Adjuvant Gefitinib

Led the IMPACT phase III trial comparing adjuvant gefitinib versus cisplatin/vinorelbine in Japanese EGFR-mutant resected NSCLC, providing key data on EGFR TKI adjuvant benefit that informed subsequent global ADAURA design.

EGFR Mutation Detection Methods

Pioneered highly sensitive EGFR mutation detection technologies applicable to surgical specimens and liquid biopsies, establishing methodological foundations adopted across Japanese and Asian oncology centers.

Representative Works 代表性著作

[1]

Gefitinib versus Cisplatin plus Vinorelbine as Adjuvant Setting in Patients with EGFR-Mutated Completely Resected Stage II-IIIA NSCLC (IMPACT, WJOG 6410L)

Journal of Clinical Oncology (2021)

Phase III IMPACT trial demonstrating gefitinib DFS benefit versus chemotherapy in EGFR-mutant resected NSCLC, contributing to adjuvant TKI evidence base.

[2]

Mutations of the Epidermal Growth Factor Receptor Gene and Related Genes as Determinants of Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Sensitivity in Lung Cancer

Cancer Science (2010)

Foundational review establishing EGFR mutation landscape and its deterministic role in TKI sensitivity, widely cited in Japanese thoracic oncology.

🏆Awards & Recognition 奖项与荣誉

🏆Japanese Lung Cancer Society Outstanding Research Award
🏆Japanese Society of Medical Oncology Distinguished Contribution Award
🏆Asia Pacific Lung Cancer Conference Keynote Award

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 光冢哲也 的研究动态

Follow Tetsuya Mitsudomi's research updates

留下邮箱,当我们发布与 Tetsuya Mitsudomi(Kindai University Faculty of Medicine)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment